PL116944B1 - Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov - Google Patents
Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov Download PDFInfo
- Publication number
- PL116944B1 PL116944B1 PL1978215923A PL21592378A PL116944B1 PL 116944 B1 PL116944 B1 PL 116944B1 PL 1978215923 A PL1978215923 A PL 1978215923A PL 21592378 A PL21592378 A PL 21592378A PL 116944 B1 PL116944 B1 PL 116944B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- trans
- pyrido
- compounds
- indoles
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title claims description 3
- 238000004519 manufacturing process Methods 0.000 title description 3
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 125000001153 fluoro group Chemical group F* 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical group [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- -1 phenylalkyl radical Chemical class 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical group C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000017105 transposition Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- YHYKLKNNBYLTQY-UHFFFAOYSA-N 1,1-diphenylhydrazine Chemical compound C=1C=CC=CC=1N(N)C1=CC=CC=C1 YHYKLKNNBYLTQY-UHFFFAOYSA-N 0.000 description 1
- BPPMRCNUQCVVFJ-UHFFFAOYSA-N 2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical class N1C2=CC=CC=C2C2C1CCNC2 BPPMRCNUQCVVFJ-UHFFFAOYSA-N 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000008038 benzoazepines Chemical class 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- UIOFNRJCXIGQFZ-UHFFFAOYSA-N n-(3,4-difluorophenyl)-3,3-dimethyl-4h-isoquinolin-1-amine Chemical compound N=1C(C)(C)CC2=CC=CC=C2C=1NC1=CC=C(F)C(F)=C1 UIOFNRJCXIGQFZ-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- DITHIFQMPPCBCU-UHFFFAOYSA-N propa-1,2-diene Chemical compound [CH]=C=C DITHIFQMPPCBCU-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 239000008237 rinsing water Substances 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Przedmiotem wynalazku jest sposób wytwarza¬ nia nowych 4a,9b-trans-5-arylo-2,3,4,4a,5,9b-szescio- wodoro-lH-pirydo-[4,3-b]indoIi o wzorze 1, w któ¬ rym X i Y oznaczaja atomy fluoru, stanowiacych zwiazki wyjsciowe w syntezie nowych podstawio¬ nych w pozycji 2 4a,9ib-trans-5-arylo-2,3,4,4a,5,9b- -szesciowodoro-lH pirydo[4,3-b]indo!i (szesciowodo- ro-y-karbolin) i dopuszczalnych w farmacji soli tych zwiazków, wykazujacych dzialanie uspokajajace.Po wprowadzeniu do psychoterapii we wczesnych latach 1950 rezerpiny i chloropromazyny, znaczny wysilek skierowano na poszukiwanie innych czyn¬ ników uspokajajacych, o lepszym profilu biologicz¬ nym. Znaleziono kilka zwiazków czynnych w grupie pirydo[4,3-b}indoli, zwanych y-karbolinami.W opisie patentowym St. Zjedn. Ameryki nr 3 687 961 przedstawiono 8-fluoro-2-[3-/4-fluorofe- nyloanilino/propylo]-l,2,3,4-czterowodoro-y-kar- boline jako uzyteczny czynnik uspokajajacy dla zwierzat cieplokrwistych. W opisie patentowym St.Zjedn. Ameryki nr 3 755 584 stwierdzono, ze podob¬ na czynnosc wykazuja zwiazki pokrewne, z ato¬ mami fluoru, w pozycjach 6 lub 8. a zwlaszcza zwiazki podstawione w pozycji 2 rodnikiem feny- loalkilowym z podstawnikiem para pierscienia fe nylowego.W opisie patentowym St. Zjedn. Ameryki nr 3 983 239 przedstawiono szesciowodoro-y-karboliny o wzorze 8, w którym R1 oznacza rodnik metylo¬ wy lub etylowy, a R2 oznacza atom wodoru, rod¬ nik metylowy lub rodnik etylowy. W opisie nie wspomina sie o stereochemicznej wspólzaleznosci atomów wodoru zwiazanych z atomami wegla w pozycjach 4a i 9b. Mozna jednak oczekiwac, ze a a"omy te sa we wzajemnym polozeniu cis, ponie¬ waz zwiazki otrzymano przez katalityczne uwodor¬ nienie odpowiednich 1,2,3,4-czterowodoro-y-karbo- lin w obecnosci platyny, a jak wiadomo, atomy wodoru wprowadzone tym sposobem do podwój- 10 nego wiazania wegiel-wegiel znajduja sie we wza¬ jemnym polozeniu cis. Zwiazki o wzorze 8 zastrze¬ zono jako neuroleptyki, uzyteczne w leczeniu schi¬ zofrenii.W opisie patentowym St. Zjedn. Ameryki nr U 3 991 199 przedstawiono szesciowodoropirydo[4,3-b] indole, uzyteczne jako srodki przeciwbólowe i psy¬ chotropowe. Niektóre z nich sa interesujace jako srodki uspokajajace, natomiast inne jako czynniki zwalniajace napiecie miesni. Wie-e z nich wykazuje 20 czynnosc hopotensyjna. W opisanych zwiazkach atomy wodoru przy atomach wegla w pozycjach 4a i 9b we wzajemnym polozeniu trans. Zwiazki przedstawia ogólny wzór 9, w którym gdy Ya oz¬ nacza -H, Xa oznacza -H, -Cl, -Br, -CH3, -III rz. 25 G4H9 lub -OCH3, a gdy Ya=-OF3, to Xa=-H; a Ra oznacza atom wodoru lub rodnik 2-/3-chloro/ /butenylowy, 2-bromoallilowy, benzylowy, benzy¬ lowy podstawiony rodnikiem metylowym, grupa metoksylowa lub atomem chloru, fenyloetylowy, 30 3-fenylopropylowy, 3-fenylopropylowy, podstawio- 116 944116 644 3 ny w pierscieniu atomem chloru lub bromu lub grupa metoksylowa, furfurylowy, 2-tienylowy, Cj-Cs-alkilowy, C8-C6-alkenylowy, Cs-C5-alkinylo- wy, cynamylowy, cynamylówy podstawiony w pier¬ scieniu atomem chloru, atomem bromu lub grupa metoksylowa, 2-/3-fenylo/propynylowy, C8-C7-cy- kloalkilowy, C4-C8-cykloalkilometylowy, /metylocy- klopropylo/metylowy, /cis-2,3-dwumetylocyklopro- pylo/metylowy, C6-C7-cykloalkenylometyloWy, C6- -C8-cykloalkinylometylowy, [l-/2,3-dwumetylocyklo- propen-2/ylo]-metylowy egzo-7-norkarylometylo- wy, [7-/cis-lj6-dwumetylo-endb*3*noTkaTen7ylo] me¬ tylowy, l-/4-mstylóbicyklo[2.2.2]oktylo/rhetylowy l-/4-metylobicyklo]2.2.2[okten-2-ylo/-metylowy, 5-/bicyklo[2.2.2.]lrepten-^-ylo/metylowy, 1-adamah* tylometylowy lub 2-adamantylometylowy.W belgijskim opisie patentowym nr 845 368 (Derwent No. 00043Y) przedstawiono 5-fenylosze^ sciowódoro-y-karboliny, ewentualnie podstawione w pozycjach 2 i 4 rodnikami metylowymi lub ety¬ lowymi, a w pozycji 3 rodnikiem alkilowym o 1-3 atomach wegla, rodnikiem allilowym lub rodnikiem propargilowym. Zwiazki te sa uzyteczne jako czyn¬ niki antydepresyjne.W ogloszeniowym opisie patentowym RFN nr 2 631836 (Derwent No 0988Y) opisano struktural¬ nie zblizone osmiowodoropirydo[4',3':2,3] indolo [1,7-ab] [l]benzazepiny, które mozna przedstawic wzorem 9, w którym Ya oznacza mostek etyterló* wy miedzy dwdffla pier§ai6fiiami benzenowymi, X* oznacza atom wodoru, a Ra oznacza grupe -CH2CH2COCH8 lub -CH2CH2COC6H5. Zwiazki te sa uzyteczne jako czynniki przeciwbólowe i uspo¬ kajajace.W Opisie patentowym 5t; Zjedn. Ameryki nr 4 001 fttil przedstawiono dzialajace uspokajajaco 5*arylO*I,2jM*e^teroWodofo*^karT3olin^ o wzorze 1 oztiadliaja atom wodoru lub fluoru, a Rb oznacza rodnik metylowy, grupe, ó WzOfze ^/CH^M-C^Z lUb */Gtt8/nl-CH=CH- -C6H4Z, w których to wzorach n jest równe 3 lub 4, m jdst równe 2 lub 3, M oznacza -CO- lub -CH/OH/-, a Z ozn&eza wodór, fluor lub grupe me¬ toksylowa, Nieoezdkiwafttó stWtefdZóno, ze zttacznie wy2s*a eiynnosc uspokajaja niz l^^^-CKt^towodoi-o^- karboliny maja trans-2,3,4,4a,5,9b-szesciowddóró- -lH-#ifydO[4,3-b]i*ldole o wiórze ógólftym 3, w którym X i Y &mettjA atomy fluofu, n ózhaetó liczbe 3 lub 4, M OZnasza grtipc o WZófzg 4 lub 5, a Z oznacza atom wodoru, fluoru lub gfujfc fflcto- ksylowa oraz dopuszczalne w farmacji sole tych zwiazków albo o wzorze Ó, w Którym X i Y fflafó wyl«j podane znficzenie, m oznacza HOZbe 2 Ittb 3, a z oznacza atom fluoru lub gfupe metoksylowa otfaz dopuszczalne w farmacji sole tych zwiazków, w$ wzajamnyin polozeniu trans s$ w iym zwkjz* kach atomy wodoru przy at<*ma Stwierdzono, ze zwózki o wzorze 3, w którym X i Y ózriaczaft atomy fluoru wykazuja nieocze¬ kiwane, korzystne dzialania przy niskiej dawce, utrzymujace sie na tym samym poziomic aktywno¬ sci pitst do najmniej 24 godziny. 2wi4zki o wzorze l, wytwarzane sposobem We¬ dlug wynalazku sa zwiazkami wyjsciowymi do wytwarzania zwiazków ó WzófzG 3, stanowiacych niespodziewanie aktywne zwiazki finalne.Sposób wedlug wynalazku Wytwarzania zwiaz¬ ków o wzorze 1, w którym X i Y oznaczaja ato- s my fludru, polega na tym, ze na 4a,9b-trans-2,3,4, 4a,5,9b-szesciowOdoro-lH-pirydo[4,3-b]-indol o wzo¬ rze 2, w którym Xi Y maja wyiaj podane zna¬ czenie, a R2 oznacza rodnik beniyloWy, dziala sie wodorem w obecnosci palladu na WgglU. io Reakcje zazwyczaj przeprowadza sie na chlorowo¬ dorku zwiazku o wzorze 2, w 50-100, korzystnie 00—75°Cj pod cisnieniem wodoru, 1,4—7 kG/cm2, w obecnosci obojetnego w reakcji rozpuszczalnika, np. metanolu, etanolu, izopropanolu, octanu etylu ii lUb mieszanin tych rozpuszczalników z „ woda. Po zakonczeniu pochlaniania wodoru óds^czU lici kata¬ lizator, a zwiazek o wzorze 1 wytraca w postaci ehldroWodorku* dodaniem np. eteru etyioWego, ben¬ zenu lub heksanu. Alternatywnie mozna zwiazek w o wzorze 1 wyodrebnic w postaci wolnej zasady, odparowujac przesacz i reakcji odbenzylowania do sucha i poddajac pozostalosc rozdzialowi miedzy wodny roztwÓi* wodorotlenku metalu alkalicznego, ftp. Wodorotlenku sodu, a rozpuszczalnik, jak chlo- M roform lub eter etylowy. Wolna zasade wyodreb¬ nia sie nastepnie znanymi metodami.Materialy wyjsciowe wytwarza sie w sposób na¬ stepujacy* 2-benzylo-5-fenylo-l,2,3,4-czterowodora- -y-karboline otrzymuje sie w syntezie indoli we- *L dlUg Fischera z N,N-dwufenylohydrazyny i N-ben- zylopiperydonu-4. Wyjsciowe mono- lub dwufluoro- czterowodoro-y-karboliny o wzorze 7, w których co najmniej jeden sposród podstawników X, Y ozna~ cza atom fluoru, a Rf oznacza rodnik benzylowy, M otrzymuje sie z odpowiednich zwiazków o wzorze 7, w których fe2 oznacza atom wodoru, w reakcji z halogenkiem benzylu, jak bromek benzylu, uzy¬ tym w równomolowej ilosci. Zwiazki o wzorze l, w którym R£=H otrzymuje sie jak w opisie paten- 40 toWym St. Zjedn. Ameryki nr 4 0Ó1Z63.Ponizszy przyklad ilustruje sposób wedlug Wyna¬ lazku; P r a y k l a d. D,L-trans*8~fluoro^5-/p-£luoroferiy- 45 lo/-2y3,4,4a,5,9b*sz€s€Jiowodoro-lH-pirydo[4/3-b]ihdol.W szklanym riaczyriiu cisriieftlowyrii umi6szczsl sie 780 g &k palladu na Weglu, ilW hii Wódy, 18W,5 g (3,W mola) chlófOWOdóYkU fi,L-trafls^-ben- zylo-S-flUóffd^^/p^lttórdfehyló/^^^,^^,^ sa£s* 5o ciówodofÓ*lti-plryaó[4,3^b]indólU i 86,1 litra meta¬ nolu. Reaktor pf^plukujd sie azótem, nastepnik wodorem, po e*zyni wypeinia sie go Wodorem1 pód ciihieriteiri 84S.10* Pz i prowadzi reakcje uwócfór- riieriia W temtfefattirze 25—4l°C, w ciagu okolo 55 2 godzin. Reaktor c^ftfWieifza sie, przeplukuje' kio- tettt, po ttytfi rnieszarttrie reakcyjna przesacza *ie W celu Usurliecia katalizatora, fsatalizstóf przemy¬ wa Sle fneinn&stn, pó czytn pfZe^^Cz f popluczyny odparowuje sie #00 z^ririieiszdriynl cisriientóhi. fifó 80 pozostalosci dodaje sie 28 litrów chlorku metylenu i 87 iitfdw Wody, zawierajacej 852 g Wódófótlenku sddd. Otrzym^h^ friieszlaniri^ miesza sie. przez 10 rninut pr*y Wartosci jltt^lz i rozdziela WarstWy.Wsrstw^ wodna ekstrahuje si^ nastepna ptofcja 28 •f litrów chlorku metylenu, warstwy organiczne la-116 944 Czy sie i przemywa 26,5 1 wody. Wyciagi organicz¬ ne suszy sie nad bezwodnym siarczanem magnezu i zateza po dodaniu 95 1 heksanu. Otrzymana pap¬ ke oziebia sie do temperatury 8°C, saczy, przemy¬ wa heksanem i suszy. Otrzymuje sie 1446 g (wy¬ dajnosc 67%) produktu o temperaturze topnienia 115—118°C.Analiza elementarna: dla C17H16F2N2: Obliczono: C — 71,31, H — 5,63, N — 9,79, F — 13,27 Znaleziono: C — 71,25, H — 5,50, N — 9,76, F — 13,28.Widmo masowe M/e: 286 (100, m+) 257(50), 256(72), 243(61), 242(57), 148(32), 135(36), 57(79).Zastrzezenie patentowe Sposób wytwarzania nowych 4a,9b-trans-5-arylo- -2,3,4,4a,5,9b-szesciowodoro-lH-pirydo[4,3-b]indoli o wzorze 1, w którym X i Y oznaczaja atomy flu¬ oru, znamienny tym, ze na 4a,9b-trans-2,3,4,4a,9b- szesciowodoro-lH-pirydo[4,3-b]indol o wzorze 2, w którym X i Y maja wyzej podane znaczenie, a R2 oznacza rodnik benzylowy, dziala sie wodorem w obecnosci palladu na weglu. rxX7 Wzór 1 *XXXT! « -c- OH I ¦CH- Wzór i Wzór 5 '^CQHCH2,mCH-CH^y^ Y Wzór 2 ¦(CH2)n-MH0' 1 Wzór 6 N-R^ Wzór 7 Y Wzór 3116 944 9b.N R' N-(CH2)3CO-^y-F Wzór 8 X H k^N-Ra N- Yc H X Wzór 9 ~N-Rb N Wzór 10 Bltk 844/82 80 egz. A4 Cena 100 zl PL PL PL The subject of the invention is a method for preparing new 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indoIi of formula 1, where X and Y are fluorine atoms, which are the starting compounds in the synthesis of new 4a,9ib-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H pyrido [4,3-b]indo!i (hexahydrogen-ro-y-carboline) and pharmaceutically acceptable salts of these compounds, which have a calming effect. After the introduction of reserpine and chlorpromazine into psychotherapy in the early 1950s, considerable effort was directed to the search for other treatments. calming agents with a better biological profile. Several active compounds have been found in the group of pyrido[4,3-b}indoles, called γ-carbolines. In the St. patent description United No. 3,687,961 discloses 8-fluoro-2-[3-/4-fluorophenylanilino/propyl]-1,2,3,4-tetrahydro-y-carboline as a useful sedative for warm-blooded animals. In the United States patent description No. 3,755,584, it was found that related compounds with fluorine atoms in positions 6 or 8 have similar activity, especially compounds substituted in position 2 with a phenylalkyl radical with a para substituent on the phenyl ring. In the patent description St. . United No. 3,983,239 describes hexahydrogen-y-carbolines of the formula 8, in which R1 is a methyl or ethyl radical and R2 is a hydrogen atom, a methyl radical or an ethyl radical. The description does not mention the stereochemical interdependence of hydrogen atoms bonded to carbon atoms in positions 4a and 9b. However, it can be expected that these atoms are in a cis position to each other, because the compounds were obtained by catalytic hydrogenation of the corresponding 1,2,3,4-tetrahydrogen-y-carbolines in the presence of platinum, and as is known, atoms hydrogen introduced in this way into the carbon-carbon double bond are in a mutual cis position. Compounds of formula 8 are claimed as neuroleptics, useful in the treatment of schizophrenia. In US Patent No. U 3 991 199 hexahydropyrido[4,3-b] indoles are presented, useful as analgesics and psychotropic agents. Some of them are interesting as sedatives, while others as agents releasing muscle tension. Many of them have hypotensive activity. in the described compounds, hydrogen atoms at the carbon atoms in positions 4a and 9b in the mutual trans position. The compounds are represented by the general formula 9, in which when Ya is -H, Xa is -H, -Cl, -Br, -CH3, -III .25 G4H9 or -OCH3, and when Ya=-OF3, then Xa=-H; and Ra represents a hydrogen atom or a 2-(3-chloro)butenyl, 2-bromoallyl, benzyl, benzyl radical substituted with a methyl radical, a methoxy group or a chlorine atom, phenylethyl, 3-phenylpropyl, 3-phenylpropyl, substituted 944116 644 3 in the ring with a chlorine or bromine atom or a methoxy group, furfuryl, 2-thienyl, C1-C8-alkyl, C8-C6-alkenyl, C8-C5-alkynyl, cinnamyl, cinnamyl substituted in the ring with a chlorine atom , bromine atom or methoxy group, 2-/3-phenyl/propynyl, C8-C7-cycloalkyl, C4-C8-cycloalkylmethyl, /methylcyclopropyl/methyl, /cis-2,3-dimethylcyclopropyl/methyl, C6-C7-cycloalkenylmethyl, C6-C8-cycloalkynylmethyl, [1-(2,3-dimethylcyclopropen-2/yl]-methyl exo-7-norkarylmethyl, [7-/cis-1j6-dimethyl-endb *3*noTkaTen7yl]methyl, 1-(4-methylbicyclo[2.2.2]octyl/rhetyl 1-(4-methylbicyclo]2.2.2[octen-2-yl)methyl, 5-(bicyclo[2.2. 2.1-repten-^-ylmethyl, 1-adamah*tylmethyl or 2-adamantylmethyl. In Belgian patent No. 845,368 (Derwent No. 00043Y) depicts 5-phenylsixhydrogen-y-carbolines, optionally substituted in the 2- and 4-positions by methyl or ethyl radicals, and in the 3-position by an alkyl radical with 1-3 carbon atoms, an allyl radical or a propargyl radical. These compounds are useful as antidepressants. German patent advertisement No. 2,631,836 (Derwent No. 0988Y) describes the structurally related octahydropyrido[4',3':2,3] indolo [1,7-ab] [l ]benzazepines, which can be represented by the formula 9, in which Ya is an ethyl bridge between two benzene rings, X* is a hydrogen atom, and Ra is a -CH2CH2COCH8 or -CH2CH2COC6H5 group. These compounds are useful as analgesics and sedatives. In Patent Specification 5t; United America No. 4,001 fttil, the calming 5*arylO*I,2M*e^terohydrofo*^carT3olin^ of the formula 1 is presented, which consists of a hydrogen or fluorine atom, and Rb is a methyl radical, a group, - CH^M-C^Z or */Gtt8/nl-CH=CH- -C6H4Z, in which formulas n is equal to 3 or 4, m jdst is equal to 2 or 3, M is -CO- or -CH/OH/-, and Z is hydrogen, fluorine or methoxy group, it has been found that it has a significantly higher antioxidant effect than l^^^-CKt^twater-o^- carbolines have trans-2,3,4,4a,5,9b-hexa- -lH- #ifydO[4,3-b]i*ldole with a general chip 3, in which gfujfc fflctoxy and pharmaceutically acceptable salts of these compounds or of the formula Ó, in which X and Y fflafó excluding the given meaning, m stands for HOZbe 2 Ittb 3, and z stands for a fluorine atom or gfupe methoxyl otphase, pharmaceutically acceptable salts of these compounds, in the mutual trans position there are hydrogen atoms in different compounds at the atom. It was found that compounds of the formula 3, in which X and thus limit your pits activity for at least 24 hours. The two bundles of formula I produced by the method according to the invention are the starting compounds for the production of compounds - WzófzG 3, which are unexpectedly active final compounds. The method according to the invention for the preparation of compounds of formula I, in which X and Y are the atoms of the fluid, is that the 4a,9b-trans-2,3,4, 4a,5,9b-hexas Odoro-1H-pyrido[4,3-b]-indole of the formula 2, in which X and Y are expressed given meaning, and R2 is a beniyl radical, is treated with hydrogen in the presence of palladium on WgglU. io The reactions are usually carried out on the hydrochloride of the compound of formula 2, at 50-100, preferably 00-75°C, under hydrogen pressure, 1.4-7 kG/cm2, in the presence of a solvent inert in the reaction, e.g. methanol, ethanol , isopropanol, ethyl acetate or mixtures of these solvents with water. After the hydrogen absorption is completed, the catalyst leaves the leaves and the compound of formula 1 is precipitated in the form of hydrohydride by adding e.g. ethyl ether, benzene or hexane. Alternatively, the compound of formula 1 can be isolated as the free base by evaporating the filtrate and debenzylation to dryness and partitioning the residue between an aqueous solution of alkali metal hydroxide, ftp. Sodium hydroxide and a solvent such as chloroform or ethyl ether. The free base is then isolated by known methods. The starting materials are prepared as follows: 2-benzyl-5-phenyl-1,2,3,4-tetrahydrogen-y-carboline is obtained in the synthesis of indoles in L dlUg Fischer from N,N-diphenylhydrazine and N-benzylpiperidone-4. The starting mono- or difluoro-tetrahydro-γ-carbolines of the formula 7, in which at least one of the substituents X, Y is a fluorine atom and Rf is a benzyl radical, M are obtained from the corresponding compounds of the formula 7, in which fe2 means a hydrogen atom reacted with a benzyl halide, such as benzyl bromide, used in an equimolar amount. Compounds of formula I, in which R£ = H, are obtained as described in the 40th St. patent. United Americas No. 4 0Ó1Z63. The following example illustrates the method of the Invention; EXAMPLE D,L-trans*8~fluoro^5-/p-fluoroferiyl-45/-2y3,4,4a,5,9b*s€Hiohydrogen-1H-pyrido[4/3- b]ihdol. In a glass cisrieftlowyrium there was 780 g of palladium on carbon, 18W.5 g (3.0 moles) of water, water, benzyl-S-flUoffd^^/p ^lttórdfehyló/^^^,^^,^ s^s* 5o ciówdofÓ*lti-plryaó[4,3^b]indólU and 86.1 liters of methanol. The reactor is flushed with nitrogen, then with hydrogen, then it is filled with hydrogen, then with 84S.10* Pz, and the reaction is carried out in a temperature of 25-4 l°C for about 2 hours. The reactor is heated, rinsed with kyotttt, after the reaction is filtered, in order to extract the catalyst, the catalytic converter is washed with water, the rinsing water is evaporated and evaporated. fifó 80 residues are added 28 liters of methylene chloride and 87 liters of water, containing 852 g of hydrophoxide sddd. Obtain ^h^ friieszlaniri^ mixed. for 10 minutes, the layers are separated and the water layer is extracted with 28 liters of methylene chloride, the organic layers are washed and washed with 26.5 liters of water. The organic extracts are dried over anhydrous magnesium sulfate and concentrated after adding 95 liters of hexane. The obtained slurry is cooled to 8°C, filtered, washed with hexane and dried. 1446 g (yield 67%) of product with a melting point of 115-118°C are obtained. Elemental analysis: for C17H16F2N2: Calculated: C - 71.31, H - 5.63, N - 9.79, F - 13 .27 Found: C - 71.25, H - 5.50, N - 9.76, F - 13.28. Mass spectrum M/e: 286 (100, m+) 257(50), 256(72), 243(61), 242(57), 148(32), 135(36), 57(79). Patent claim Method for producing new 4a,9b-trans-5-aryl-2,3,4,4a,5 ,9b-hexahydrogen-1H-pyrido[4,3-b]indole of the formula 1, in which X and Y are fluorine atoms, characterized in that at 4a,9b-trans-2,3,4,4a, 9b- hexahydrogen-1H-pyrido[4,3-b]indole of formula 2, in which X and Y have the meanings given above and R2 is a benzyl radical, is treated with hydrogen in the presence of palladium on carbon. rxX7 Pattern 1 *XXXT! « -c- OH I ¦CH- Formula and Formula 5 '^CQHCH2,mCH-CH^y^ Y Formula 2 ¦(CH2)n-MH0' 1 Formula 6 N-R^ Formula 7 Y Formula 3116 944 9b.N R' N -(CH2)3CO-^y-F Pattern 8 X H k^N-Ra N- Yc H X Pattern 9 ~N-Rb N Pattern 10 Bltk 844/82 80 copies A4 Price PLN 100 PL PL PL
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79939277A | 1977-05-23 | 1977-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL116944B1 true PL116944B1 (en) | 1981-07-31 |
Family
ID=25175793
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1978206903A PL114547B1 (en) | 1977-05-23 | 1978-05-18 | Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles |
PL1978215922A PL114541B1 (en) | 1977-05-23 | 1978-05-18 | Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles |
PL1978215923A PL116944B1 (en) | 1977-05-23 | 1978-05-18 | Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov |
PL1978215921A PL117107B1 (en) | 1977-05-23 | 1978-05-18 | Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles-geksagirdid 1h-pirido 4,3-b ionidolov |
PL20690379A PL206903A1 (en) | 1977-05-23 | 1979-05-18 | METHOD OF MANUFACTURING NEW SUBSTITUTED INDOLES IN POSITION 2-4A, 9B-TRANS-5-ARYL-2,3,4,4A, 5A, 9B-HIXHYDRO-1H-PYRIDO (4,3-B) |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1978206903A PL114547B1 (en) | 1977-05-23 | 1978-05-18 | Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles |
PL1978215922A PL114541B1 (en) | 1977-05-23 | 1978-05-18 | Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1978215921A PL117107B1 (en) | 1977-05-23 | 1978-05-18 | Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles-geksagirdid 1h-pirido 4,3-b ionidolov |
PL20690379A PL206903A1 (en) | 1977-05-23 | 1979-05-18 | METHOD OF MANUFACTURING NEW SUBSTITUTED INDOLES IN POSITION 2-4A, 9B-TRANS-5-ARYL-2,3,4,4A, 5A, 9B-HIXHYDRO-1H-PYRIDO (4,3-B) |
Country Status (31)
Country | Link |
---|---|
JP (1) | JPS53144600A (en) |
AR (2) | AR217688A1 (en) |
AT (1) | AT368995B (en) |
AU (1) | AU499618B1 (en) |
BE (1) | BE867249A (en) |
CA (1) | CA1094071A (en) |
CH (1) | CH634321A5 (en) |
CS (1) | CS207612B2 (en) |
DD (4) | DD146186A5 (en) |
DE (1) | DE2822465C2 (en) |
DK (1) | DK226678A (en) |
EG (1) | EG13590A (en) |
FI (1) | FI63402C (en) |
FR (1) | FR2392023A1 (en) |
GB (1) | GB1586655A (en) |
GR (1) | GR69985B (en) |
HU (3) | HU185009B (en) |
IE (1) | IE46975B1 (en) |
IL (1) | IL54755A (en) |
IT (1) | IT1096307B (en) |
LU (1) | LU79684A1 (en) |
NL (1) | NL7804210A (en) |
NO (2) | NO150204C (en) |
NZ (1) | NZ187333A (en) |
PH (1) | PH13756A (en) |
PL (5) | PL114547B1 (en) |
PT (1) | PT68058B (en) |
SE (2) | SE441448B (en) |
SU (4) | SU873883A3 (en) |
YU (4) | YU91478A (en) |
ZA (1) | ZA782918B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4224329A (en) * | 1979-01-23 | 1980-09-23 | Pfizer Inc. | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles |
US4451655A (en) * | 1982-05-17 | 1984-05-29 | Pfizer Inc. | Process for preparing carboline derivatives and compounds used in their preparation |
RU2106864C1 (en) * | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | New approach to treatment of alzheimer's disease |
SE9604786D0 (en) * | 1996-12-20 | 1996-12-20 | Astra Pharma Inc | New compounds |
US6974825B1 (en) | 1996-12-20 | 2005-12-13 | Astrazeneca Canada Inc. | Compounds with analgesic effect |
SE9904675D0 (en) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
SE0101773D0 (en) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101770D0 (en) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101769D0 (en) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101771D0 (en) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR205452A1 (en) * | 1973-12-06 | 1976-05-07 | Endo Lab | METHOD TO PREPARE NEW TRANS-2, 3, 4, 4A, 5, 9B-HEXAHYDRO-5-PHENYL-1H-PYRID (4,3-B) INDOLES |
JPS50126699A (en) * | 1974-03-20 | 1975-10-04 | ||
US4001263A (en) * | 1974-04-01 | 1977-01-04 | Pfizer Inc. | 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines |
-
1978
- 1978-03-30 SE SE7803625A patent/SE441448B/en unknown
- 1978-04-17 PH PH21013A patent/PH13756A/en unknown
- 1978-04-18 YU YU00914/78A patent/YU91478A/en unknown
- 1978-04-20 NL NL7804210A patent/NL7804210A/en not_active Application Discontinuation
- 1978-04-24 AU AU35377/78A patent/AU499618B1/en not_active Expired
- 1978-04-25 EG EG276/78A patent/EG13590A/en active
- 1978-04-28 AR AR271956A patent/AR217688A1/en active
- 1978-05-18 SU SU782615898A patent/SU873883A3/en active
- 1978-05-18 PL PL1978206903A patent/PL114547B1/en unknown
- 1978-05-18 HU HU78PI626A patent/HU185009B/en unknown
- 1978-05-18 PL PL1978215922A patent/PL114541B1/en unknown
- 1978-05-18 GB GB20350/78A patent/GB1586655A/en not_active Expired
- 1978-05-18 PL PL1978215923A patent/PL116944B1/en unknown
- 1978-05-18 CS CS783239A patent/CS207612B2/en unknown
- 1978-05-18 HU HU822638A patent/HU188802B/en unknown
- 1978-05-18 PL PL1978215921A patent/PL117107B1/en unknown
- 1978-05-18 HU HU822639A patent/HU187782B/en unknown
- 1978-05-19 DD DD215016A patent/DD146186A5/en unknown
- 1978-05-19 DD DD78205479A patent/DD138321A5/en unknown
- 1978-05-19 BE BE187842A patent/BE867249A/en not_active IP Right Cessation
- 1978-05-19 DD DD78215015A patent/DD145536A5/en unknown
- 1978-05-19 PT PT68058A patent/PT68058B/en unknown
- 1978-05-19 CA CA303,710A patent/CA1094071A/en not_active Expired
- 1978-05-19 DD DD78215017A patent/DD145537A5/en unknown
- 1978-05-20 GR GR56281A patent/GR69985B/el unknown
- 1978-05-22 IE IE1013/78A patent/IE46975B1/en unknown
- 1978-05-22 JP JP6087278A patent/JPS53144600A/en active Granted
- 1978-05-22 DK DK226678A patent/DK226678A/en not_active Application Discontinuation
- 1978-05-22 IT IT23673/78A patent/IT1096307B/en active
- 1978-05-22 AT AT0369678A patent/AT368995B/en not_active IP Right Cessation
- 1978-05-22 NO NO781770A patent/NO150204C/en unknown
- 1978-05-22 LU LU79684A patent/LU79684A1/en unknown
- 1978-05-22 NZ NZ187333A patent/NZ187333A/en unknown
- 1978-05-22 FR FR7815029A patent/FR2392023A1/en active Granted
- 1978-05-22 FI FI781612A patent/FI63402C/en not_active IP Right Cessation
- 1978-05-22 CH CH552678A patent/CH634321A5/en not_active IP Right Cessation
- 1978-05-22 IL IL54755A patent/IL54755A/en unknown
- 1978-05-22 ZA ZA00782918A patent/ZA782918B/en unknown
- 1978-05-23 DE DE2822465A patent/DE2822465C2/en not_active Expired
-
1979
- 1979-04-16 AR AR276191A patent/AR221721A1/en active
- 1979-04-24 SU SU792753359A patent/SU843749A3/en active
- 1979-04-26 SU SU792759902A patent/SU818484A3/en active
- 1979-05-18 SU SU792763595A patent/SU841589A3/en active
- 1979-05-18 PL PL20690379A patent/PL206903A1/en unknown
-
1982
- 1982-10-01 YU YU2217/82A patent/YU40796B/en unknown
- 1982-10-01 YU YU02218/82A patent/YU221882A/en unknown
- 1982-10-01 YU YU02216/82A patent/YU221682A/en unknown
-
1983
- 1983-05-20 NO NO831790A patent/NO151862C/en unknown
- 1983-10-27 SE SE8305917A patent/SE448459B/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4231290B2 (en) | Substituted pyridoindoles as agonists and antagonists of serotonin | |
EP1192165B1 (en) | Substituted heterocycle fused gamma-carbolines | |
CA2432181C (en) | Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists | |
MXPA05002622A (en) | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders. | |
PL116944B1 (en) | Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov | |
Charifson et al. | Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1, 2, 3, 4-tetrahydroisoquinolines as dopamine receptor ligands | |
WO2004078721A1 (en) | Processes for producing cyclic benzamidine derivative | |
AU684165B2 (en) | New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them | |
RU2098415C1 (en) | Method of synthesis of the substituted benzofuran derivatives or their pharmaceutically acceptable salts | |
EP1362854B1 (en) | Benzo[b[thiophene derivatives and process for producing the same | |
Kuehne et al. | Three routes to the critical C16'-C14'parf relative stereochemistry of vinblastine. Syntheses of 20'-desethyl-20'-deoxyvinblastine, and 20'-desethyl-20'-deoxyvincovaline | |
CS29991A2 (en) | Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain | |
AU736710B2 (en) | New indanol compounds, a process for their preparation and pharmaceutical compositions containing them | |
KR920003065B1 (en) | Process for preparing benzodioxyno pyrrole derivatives | |
US5272143A (en) | 6-oxoazepinoindole compounds, and pharmaceutical compositions containing them | |
Zumbrunn | The first versatile synthesis of 1-alkyl-3-fluoro-1H-[1, 2, 4] triazoles | |
PL136930B1 (en) | Method of obtaining novel derivatives of benzodiazepine | |
Cravotto et al. | A library of pyranocoumarin derivatives via a one‐pot three‐component hetero diels‐alder reaction | |
Brown et al. | Preparation of oxonanes and azonanes by oxidative ring expansion: synthesis of obtusan | |
US4996211A (en) | Substituted dibenzocycloheptenimines | |
EP1423123A1 (en) | Tetracyclic indole derivatives as 5-ht receptor ligands | |
He et al. | A Versatile Total Synthesis of 8‐Oxyberberine and Oxohomoberberines | |
MXPA05002830A (en) | Antidepressant piperidine derivatives of heterocycle-fused benzodioxans. | |
WO2021015109A1 (en) | Method for producing phenol derivative | |
Savelli et al. | Synthesis of 1H‐pyrazino [1, 2‐a] pyrido [2, 3‐e] pyrazine and 2H‐Pyrano [2, 3‐b] pyrido [2, 3‐e] pyrazine Derivatives |